Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693

Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus

Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,359

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014

Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 919

CLARITY reveals a more protracted temporal course of axon swelling and disconnection than previously described following traumatic brain injury

Weber, M. T., Arena, J. D., Xiao, R., Wolf, J. A., & Johnson, V. E. (2018) · Brain Pathology · doi:10.1111/bpa.12677 · Cited by 50

Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease

Peters, F., Salihoglu, H., Pratsch, K., Herzog, É., Pigoni, M., Sgobio, C., Lichtenthaler, S. F., Neumann, U., & Herms, J. W. (2019) · The EMBO Journal · doi:10.15252/embj.2019102345 · Cited by 44

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases

Otto, M., Lewczuk, P., & Wiltfang, J. (2008) · Methods · doi:10.1016/j.ymeth.2007.06.012 · Cited by 44

Decreased level of brain acetylcholine and memory disturbance in APPsw mice

Ikarashi, Y., Harigaya, Y., Tomidokoro, Y., Kanai, M., Ikeda, M., Matsubara, E., Kawarabayashi, T., Kuribara, H., Younkin, S. G., Maruyama, Y., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00122-2 · Cited by 46

Human IMR‐32 neuroblastoma cells as a model cell line in Alzheimer's disease research

Neill, D., Hughes, D., Edwardson, J. A., RIMA, B. K., & Allsop, D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390415 · Cited by 45

Generation of Amyloidogenic C-terminal Fragments during Rapid Axonal Transport in Vivo of β-Amyloid Precursor Protein in the Optic Nerve

Amaratunga, A., & Fine, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17268 · Cited by 44

Regenerative medicine in Alzheimer's disease

Felsenstein, K. M., Candelario, K. M., Steindler, D. A., & Borchelt, D. (2013) · Translational research · doi:10.1016/j.trsl.2013.11.001 · Cited by 43

Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma

Mare, S., Penugonda, S., Robinson, S. M., Dohgu, S., Banks, W. A., & Nuran Ercal, A. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.007 · Cited by 44

Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice

Subaiea, G. M., Adwan, L. I., Ahmed, A. H., Stevens, K. E., & Zawia, N. H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.002 · Cited by 45

Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription

Waldron, E., Isbert, S., Kern, A., Jaeger, S., Martín, A., Hébert, S. S., Behl, C., Weggen, S., Strooper, B. D., & Pietrzik, C. U. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.05.003 · Cited by 43

Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro

PAKASKI, M., BJELIK, A., HUGYECZ, M., KASA, P., JANKA, Z., & KALMAN, J. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.03.004 · Cited by 43

Concentrations of amyloid-β protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease

van Gool, W. A., Schenk, D. B., & Bolhuis, P. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90677-7 · Cited by 42

Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration.

Iverfeldt, K., Walaas, S. I., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4146 · Cited by 43

Protective mechanism of kaempferol against Aβ25-35-mediated apoptosis of pheochromocytoma (PC-12) cells through the ER/ERK/MAPK signalling pathway

Zhang, N., Xu, H., Wang, Y., Yao, Y., Liu, G., Lei, X., Sun, H., Wu, X., & Li, J. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.98199 · Cited by 42

Potential of tocotrienols in the prevention and therapy of Alzheimer's disease

Xia, W., & Mo, H. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.011 · Cited by 44

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease

Grimm, M. O. W., Haupenthal, V. J., Rothhaar, T. L., Zimmer, V. C., Grösgen, S., Hundsdörfer, B., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035879 · Cited by 48

The Identification of Biochanin A as a Potent and Selective β-Site App-Cleaving Enzyme 1 (Bace1) Inhibitor

Youn, K., Park, J., Lee, J., Jeong, W., Ho, C.-T., & Jun, M. (2016) · Nutrients · doi:10.3390/nu8100637 · Cited by 34

Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?

Castellani, R. J., Zhu, X., Lee, H., Moreira, P. I., Perry, G. L., & Smith, M. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.5.473 · Cited by 42

A Combinatorial Approach to the Identification of Dipeptide Aldehyde Inhibitors of β-Amyloid Production

Higaki, J. N., Chakravarty, S., Bryant, C. M., Cowart, L. R., Harden, P., Scardina, J. M., Mavunkel, B. J., Luedtke, G. R., & Cordell, B. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990009f · Cited by 42

The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease

Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 41

Controlling amyloid growth in multiple dimensions

Dong, J., Lu, K., Lakdawala, A. S., Mehta, A. K., & Lynn, D. G. (2006) · Amyloid · doi:10.1080/13506120600960809 · Cited by 41

Post-transcriptional Contribution of a cAMP-dependent Pathway to the Formation of α- and β/γ-Secretases-Derived Products of βAPP Maturation in Human Cells Expressing Wild-type and Swedish Mutated βAPP

Marambaud, P., Chevallier, N., Ancolio, K., & Checler, F. (1998) · Molecular Medicine · doi:10.1007/bf03401766 · Cited by 42

γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β

Grimm, H. S., Beher, D., Lichtenthaler, S. F., Shearman, M. S., Beyreuther, K. T., & Hartmann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210380200 · Cited by 40

ALZHEIMER'S SOLUBLE AMYLOID BETA PROTEIN IS SECRETED BY HEPG2 CELLS AS AN APOLIPOPROTEIN

Koudinov, A. R., & Koudinova, N. V. (1997) · Cell Biology International · doi:10.1006/cbir.1996.0126 · Cited by 41

Amyloid precursor protein is enriched in radial glia: Implications for neuronal development

Trapp, B. D., & Hauer, P. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370413 · Cited by 43

β-Amyloid Peptide Produced in Vitro Is Degraded by Proteinases Released by Cultured Cells

Naidu, A., Quon, D. H., & Cordell, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1369 · Cited by 40

Molecular Rationale for the Pharmacological Treatment of Alzheimer??s Disease

Zimmermann, M., Gardoni, F., & Luca, M. D. (2005) · Drugs & Aging · doi:10.2165/00002512-200522001-00003 · Cited by 41

γ-Secretase Modulator in Alzheimer's Disease: Shifting the End

Xia, W., Wong, S. T. C., Hanlon, E. B., & Morin, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120751 · Cited by 40

Morphological Development of β(1-40) Amyloid Fibrils

Blackley, H. K. L., Patel, N., Davies, M. C., Roberts, C. J., Tendler, S. J. B., Wilkinson, M. J., & Williams, P. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7114 · Cited by 39

Amyloid precursor protein truncated at any of the ?-secretase sites is not cleaved to ?-amyloid

Paganetti, P., Lis, M., Klafki, H.-W., & Staufenbiel, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961101)46:3 · Cited by 39

Alzheimer's disease-associated presenilin 1 in neuronal cells: Evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment

Culvenor, J. G., Maher, F., Evin, G. M., Malchiodi‐Albedi, F., Cappai, R., Underwood, J. R., Davis, J. B., Karran, E. H., Roberts, G. W., Beyreuther, K. T., et al. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6 · Cited by 76

Effects of nicotine on APP secretion and Aβ- or CT105-induced toxicity

Seo, J., Kim, S., Kim, H.-S., Park, C. H., Jeong, S., Lee, J., Choi, S. H., Chang, K., Rah, J., Koo, J., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01124-0 · Cited by 40

Inhibition of nuclear factor kappa B (NF?B) activity induces nerve growth factor-resistant apoptosis in PC12 cells

Taglialatela, G., Robinson, R. C., & Perez-Polo, J. R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970115)47:2 · Cited by 170

Mutant and native human β-amyloid precursor proteins in transgenic mouse brain

Howland, D. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00078-s · Cited by 40

FAP Mutations Destabilize Transthyretin Facilitating Conformational Changes Required for Amyloid Formation

Colón, W., Lai, Z., McCutchen, S. L., Miroy, G. J., Strang, C. J., & Kelly, J. W. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514924.ch14 · Cited by 40

High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid β peptide (Aβ)

Haugabook, S. J., Yager, D. M., Eckman, E. A., Golde, T. E., Younkin, S. G., & Eckman, C. B. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00388-0 · Cited by 39

Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

Kolaj, I., Liyanage, S. I., & Weaver, D. F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.001 · Cited by 39

Large Quantities of Aβ Peptide Are Constitutively Released during Amyloid Precursor Protein Metabolism in Vivo and in Vitro

Moghekar, A., Rao, S. B., Li, M., Ruben, D. S., Mammen, A. L., Tang, X., & O’Brien, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191262 · Cited by 40

Rapid Assembly of Amyloid-β Peptide at a Liquid/Liquid Interface Produces Unstable β-Sheet Fibers

Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., & Rosenberry, T. L. (2004) · Biochemistry · doi:10.1021/bi048846t · Cited by 39

Amyloid β-peptide is produced by cultured cells during normal metabolism: A reprise

Selkoe, D. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s319 · Cited by 39

Heparin promotes ß-secretase cleavage of the Alzheimer's amyloid precursor protein

Leveugle, B. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00103-9 · Cited by 39

Role of Endoplasmic Reticulum, Endosomal–Lysosomal Compartments, and Microtubules in Amyloid Precursor Protein Metabolism of Human Neurons

LeBlanc, A. C., & Goodyer, C. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721832.x · Cited by 39

Factors influencing the processing and function of the amyloid β precursor protein—a potential therapeutic target in Alzheimer's disease?

Coughlan, C. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 39

Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines

Mandler, M., Santic, R., Gruber, P., Cinar, Y., Pichler, D., Funke, S. A., Willbold, D., Schneeberger, A., SCHMIDT, W. A., & Mattner, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115237 · Cited by 38

Abrogation of type-I interferon signalling alters the microglial response to Aβ1–42

Moore, Z., Mobilio, F., Walker, F. R., Taylor, J. M., & Crack, P. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59917-0 · Cited by 38

Intramembrane Proteolysis of GXGD-type Aspartyl Proteases Is Slowed by a Familial Alzheimer Disease-like Mutation

Fluhrer, R., Fukumori, A., Martin, L., Grammer, G., Haug‐Kröper, M., Klier, B., Winkler, E., Kremmer, E., Condron, M. M., Teplow, D. B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806092200 · Cited by 38

Axon degeneration is key component of neuronal death in amyloid-β toxicity

Alobuia, W. M., Xia, W., & Vohra, B. P. S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.013 · Cited by 38

Search for Amyloid-Binding Proteins by Affinity Chromatography

Calero, M., Rostagno, A. A., & Ghiso, J. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_15 · Cited by 37

Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau.

Islam, K., & Levy, E. (1997) · Europe PMC (PubMed Central) · Cited by 40

Receptor‐coupled Amyloid Precursor Protein Processinga

Nitsch, R. M., Slack, B. E., Farber, S. A., Borghesani, P. R., SCHULZ, J. G., KIM, C., Felder, C. C., Growdon, J. H., & Wurtman, R. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23039.x · Cited by 38

APP processing, Aβ-amyloidogenesis, and the pathogenesis of Alzheimer's disease

Gandy, S., Caporaso, G. L., Buxbaum, J. D., Frangione, B., & Greengard, P. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90125-2 · Cited by 39

Overexpression of nicastrin increases Aß production

Murphy, M. P., Das, P., Nyborg, A. C., Rochette, M. J., Dodson, M. W., Loosbrock, N., Souder, T., McLendon, C., Merit, S. L., Piper, S. C., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1050fje · Cited by 38

Alzheimer's amyloid beta and lipid metabolism: a missing link?

Koudinov, A. R., Berezov, T. T., & Koudinova, N. V. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1097 · Cited by 38

Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease

Chung, J., Zhang, X., Allen, M., Wang, X., Ma, Y., Beecham, G. W., Montine, T. J., Younkin, S. G., Dickson, D. W., Golde, T. E., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0349-z · Cited by 37

Damage Mechanisms to Oligodendrocytes and White Matter in Central Nervous System Injury: The Australian Context

Warnock, A., Toomey, L. M., Wright, A. J., Fisher, K., Won, Y., Anyaegbu, C. C., & Fitzgerald, M. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6890 · Cited by 36

Impact of ZnO on structural and electrochemical properties of silver spinel ferrites for asymmetric supercapacitors

Rehman, A. U., Batool, Z., Ahmad, M., Iqbal, M. W., Haq, A. U., & Hegazy, H. H. (2023) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2023.117206 · Cited by 37

Amyloid β peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology

Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 37

Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons

Yang, T.-T., Hsu, C.-T., & Kuo, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0311-0 · Cited by 38

Alzheimer Aβ Amyloid Forms an Inhibitory Neuronal Substrate

Eraser, P. E., Lévesque, L., & McLachlan, D. R. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031227.x · Cited by 37

Relationship between serum α1-antichymotrypsin and Alzheimer's disease

Hinds, T. R., Kukull, W. A., van Belle, G., Schellenberg, G. D., Villacres, E. C., & Larson, E. B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90141-4 · Cited by 37

Biochemistry of Alzheimer's disease amyloid plaques

Fraser, P. E., Lévesque, L., & McLachlan, D. R. C. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90110-r · Cited by 38

Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A‚-containing lesions in brains of patients with dementia of the Alzheimer type

Verbeek, M. M., Otte‐Höller, I., Wesseling, P., Ruiter, D. J., & de Waal, R. M. W. (1996) · Acta Neuropathologica · doi:10.1007/s004010050474 · Cited by 38

Activity of α‐Secretase as the Common Final Effector of Protein Kinase C‐Dependent and ‐Independent Modulation of Amyloid Precursor Protein Metabolism

Racchi, M., Solano, D. C., Sironi, M., & Govoni, S. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722464.x · Cited by 37

Transthyretin Accelerates Vascular Aβ Deposition in a Mouse Model of Alzheimer's Disease

Wati, H., Kawarabayashi, T., Matsubara, E., Kasai, A., Hirasawa, T., Kubota, T., Harigaya, Y., Shoji, M., & Maeda, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00166.x · Cited by 36

Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding

Bateman, D. A., McLaurin, J., & Chakrabartty, A. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-29 · Cited by 36

On the metal ion (Zn2+, Cu2+) coordination with beta-amyloid peptide: DFT computational study

Marino, T., Russo, N., Toscano, M., & Pavelka, M. (2010) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-010-0086-x · Cited by 35

Computational Insights into Aspartyl Protease Activity of Presenilin 1 (PS1) Generating Alzheimer Amyloid β-Peptides (Aβ40 and Aβ42)

Singh, R. R. P., Barman, A., & Prabhakar, R. S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp811154w · Cited by 36

Soluble Aβ homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins

Matsubara, E., Sekijima, Y., Tokuda, T., Urakami, K., Amari, M., Shizuka‐Ikeda, M., Tomidokoro, Y., Ikeda, M., Kawarabayashi, T., Harigaya, Y., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.004 · Cited by 36

Targeted Antioxidant, Catalase–SKL, Reduces Beta‐Amyloid Toxicity in the Rat Brain

Nell, H. J., Au, J. L., Giordano, C. R., Terlecky, S. R., Walton, P. A., Whitehead, S. N., & Cechetto, D. F. (2016) · Brain Pathology · doi:10.1111/bpa.12368 · Cited by 36

Accumulation of the Amyloid-β Precursor Protein in Multivesicular Body-like Organelles

Verbeek, M. M., Otte‐Höller, I., Fransen, J. A. M., & de Waal, R. M. W. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000509 · Cited by 36

Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis

Golde, T. E., & Eckman, C. B. (2003) · Science Signaling · doi:10.1126/stke.2003.172.re4 · Cited by 36

Molecular Determinants of the Interaction Between the C‐Terminal Domain of Alzheimer's β‐Amyloid Peptide and Apolipoprotein E α‐Helices

Lins, L., Thomas‐Soumarmon, A., Pillot, T., Vandekerckhove, J. S., Rosseneu, M., & Brasseur, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730758.x · Cited by 36

Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells

Olesen, O. F., Dagø, L., & Mikkelsen, J. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00096-5 · Cited by 36

Are β-sheet breaker peptides dissolving the therapeutic problem of Alzheimer’s disease?

Permanne, B., Adessi, C., Fraga, S., Frossard, M., Saborı́o, G. P., & Soto, C. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_27 · Cited by 34

Proteolytical processing of mutated human amyloid precursor protein in transgenic mice

Czech, C., Delaère, P., Macq, A. F., Reibaud, M., Dreisler, S., Touchet, N., Schombert, B., Mazadier, M., Mercken, L., Theisen, M., et al. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00039-9 · Cited by 36

Gold nanoparticles assisted sensitivity improvement of interdigitated microelectrodes biosensor for amyloid-β detection in plasma sample

Yoo, Y. K., Kim, G., Park, D., Kim, J., Kim, Y. S., Kim, H. Y., Yang, S. H., Lee, J. H., & Hwang, K. S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127710 · Cited by 35

Processing of β-Amyloid Precursor Protein by Cathepsin D

Higaki, J. N., Catalano, R., Guzzetta, A. W., Quon, D. H., Navé, J.-F., Tarnus, C., d'Orchymont, H., & Cordell, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31885 · Cited by 35

Alzheimer s disease and heparan sulfate proteoglycan

Fukuchi, K.-I. (1998) · Frontiers in bioscience · doi:10.2741/a277 · Cited by 35

Beta 2 microglobulin isoforms in healthy individuals and in amyloid deposits

Argilés, À., Garcia-Garcia, M., Derancourt, J., Mourad, G., & DEMAILLE, J. G. (1995) · Kidney International · doi:10.1038/ki.1995.428 · Cited by 35

Analysis of brain proteins in Alzheimer’s disease using high-resolution two-dimensional gel electrophoresis

Tsuji, T., Shimohama, S., Kamiya, S., Sazuka, T., & Ohara, O. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00120-3 · Cited by 35

Roles for calcium signaling in structural plasticity and pathology in the hippocampal system.

Mattson, M. P., & Barger, S. W. (1993) · PubMed · Cited by 35

Processing of the Platelet Amyloid Precursor Protein in the Mild Cognitive Impairment (MCI)

Bermejo‐Bescós, P., Martín‐Aragón, S., Jiménez‐Aliaga, K., Benedı́, J., Felici, E., Gil, P., Ribera, J. M., & Villar, A. M. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1039-7 · Cited by 33

Wafer-scale high-resolution patterning of reduced graphene oxide films for detection of low concentration biomarkers in plasma

Kim, J., Chae, M.-S., Lee, S., Jeong, D., Lee, B. C., Lee, J. H., Kim, Y. S., Chang, S. T., & Hwang, K. S. (2016) · Scientific Reports · doi:10.1038/srep31276 · Cited by 34

The solution structure of rat Aβ-(1–28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain

Huang, J. Y., Yao, Y., Lin, J., Ye, Y., Sun, W., & Tang†, W.-X. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0556-x · Cited by 34

Cerebral ? amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid

Sugihara, S., Ogawa, A., Nakazato, Y., & Yamaguchi, H. (1995) · Acta Neuropathologica · doi:10.1007/bf00294312 · Cited by 34

Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Diseasea

Golde, T. E., Cai, X.-D., Shoji, M., & Younkin, S. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23036.x · Cited by 35

Exploring Alzheimer's Disease in Zebrafish

Xia, W. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1412 · Cited by 37

Plasma levels of amyloid ? 40 and 42 are independent from ApoE genotype and mental retardation in down syndrome

Cavani, S., Tamaoka, A., Moretti, A., Marinelli, L., Angelini, G., Stefano, S. D., Piombo, G., Cazzulo, V., Matsuno, S., Shoji, S., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001127)95:3 · Cited by 33

Immunohistochemical study of constituents other than β-protein in canine senile plaques and cerebral amyloid angiopathy

Uchida, K., Kuroki, K., Yoshino, T., Yamaguchi, R., & TATEYAMA, S. (1997) · Acta Neuropathologica · doi:10.1007/s004010050615 · Cited by 34

The Amyloid Peptide and Its Precursor in Alzheimer's Disease

Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 34

Calpain inhibitor I decreases βA4 secretion from human embryonal kidney cells expressing β-amyloid precursor protein carrying the APP670/671 double mutation

Klafki, H.-W., Paganetti, P., Sommer, B., & Staufenbiel, M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12122-k · Cited by 34

Secretases as therapeutic targets for the treatment of Alzheimer's disease

Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 35

1950 MHz radiofrequency electromagnetic fields do not aggravate memory deficits in 5xFAD mice

Son, Y., Jeong, Y. J., Kwon, J. H., Choi, H., Pack, J., Kim, N., Lee, Y., & Lee, H. (2016) · Bioelectromagnetics · doi:10.1002/bem.21992 · Cited by 33

Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans

Sarasija, S., & Norman, K. R. (2018) · Antioxidants · doi:10.3390/antiox7090111 · Cited by 31

Emerging evidence for the neuroprotective role of α-synuclein

Lee, H., Zhu, X., Takeda, A., Perry, G. L., & Smith, M. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.024 · Cited by 37

Presenilin endoproteolysis is an intramolecular cleavage

Brunkan, A. L., Martínez, M., Walker, E. S., & Goate, A. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.12.012 · Cited by 33

Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies

Nishida, K., Quantock, A. J., Dota, A., Choi-Miura, N.-H., & Kinoshita, S. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.10.1178 · Cited by 33

Alzheimer's Disease-Linked Mutation of Presenilin 2 (N141I-PS2) Drastically Lowers APPα Secretion: Control by the Proteasome

Marambaud, P., da Costa, C. A., Ancolio, K., & Checler, F. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9619 · Cited by 33

Distribution of neprilysin and deposit patterns of Aβ subtypes in the brains of aged squirrel monkeys (Saimiri sciureus)

Chambers, J. K., Kuribayashi, H., Ikeda, S.-I., & Une, Y. (2010) · Amyloid · doi:10.3109/13506129.2010.483119 · Cited by 32

Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity

Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32

Production of Amyloid β Protein from Normal Amyloid β‐Protein Precursor (βAPP) and the Mutated βAPPS Linked to Familial Alzheimer's Diseasea

Golde, T. E., Cai, X.-D., Shoji, M., & Younkin, S. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23036.x · Cited by 35

Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor

Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913

Normal Cellular Processing of the β‐Amyloid Precursor Protein Results in the Secretion of the Amyloid β Peptide and Related Moleculesa

Haass, C., Hung, A. Y., Schlossmacher, M. G., Oltersdorf, T., Teplow, D. B., & Selkoe, D. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23037.x · Cited by 123

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921

Production of the Alzheimer's β‐amyloid peptide by C6 glioma cells

Morato, E., & Mayor, F. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80819-g · Cited by 10